Successful infection by enteric bacterial pathogens depends on the ability of the bacteria to colonize the gut, replicate in host tissues and disseminate to other hosts. Pathogens such as Salmonella, Shigella and enteropathogenic and enterohaemorrhagic (EPEC and EHEC, respectively) Escherichia coli use a type III secretion system (T3SS) to deliver virulence effector proteins into host cells during infection that promote colonization and interfere with antimicrobial host responses 1-3 . Here we report that the T3SS effector NleB1 from EPEC binds to host cell death-domain-containing proteins and thereby inhibits death receptor signalling. Protein interaction studies identified FADD, TRADD and RIPK1 as binding partners of NleB1. NleB1 expressed ectopically or injected by the bacterial T3SS prevented Fas ligand or TNF-induced formation of the canonical death-inducing signalling complex (DISC) and proteolytic activation of caspase-8, an essential step in death-receptor-induced apoptosis. This inhibition depended on the N-acetylglucosamine transferase activity of NleB1, which specifically modified Arg 117 in the death domain of FADD. The importance of the death receptor apoptotic pathway to host defence was demonstrated using mice deficient in the FAS signalling pathway, which showed delayed clearance of the EPEC-like mouse pathogen Citrobacter rodentium and reversion to virulence of an nleB mutant. The activity of NleB suggests that EPEC and other attaching and effacing pathogens antagonize deathreceptor-induced apoptosis of infected cells, thereby blocking a major antimicrobial host response.
Successful infection by enteric bacterial pathogens depends on the ability of the bacteria to colonize the gut, replicate in host tissues and disseminate to other hosts. Pathogens such as Salmonella, Shigella and enteropathogenic and enterohaemorrhagic (EPEC and EHEC, respectively) Escherichia coli use a type III secretion system (T3SS) to deliver virulence effector proteins into host cells during infection that promote colonization and interfere with antimicrobial host responses 1-3 . Here we report that the T3SS effector NleB1 from EPEC binds to host cell death-domain-containing proteins and thereby inhibits death receptor signalling. Protein interaction studies identified FADD, TRADD and RIPK1 as binding partners of NleB1. NleB1 expressed ectopically or injected by the bacterial T3SS prevented Fas ligand or TNF-induced formation of the canonical death-inducing signalling complex (DISC) and proteolytic activation of caspase-8, an essential step in death-receptor-induced apoptosis. This inhibition depended on the N-acetylglucosamine transferase activity of NleB1, which specifically modified Arg 117 in the death domain of FADD. The importance of the death receptor apoptotic pathway to host defence was demonstrated using mice deficient in the FAS signalling pathway, which showed delayed clearance of the EPEC-like mouse pathogen Citrobacter rodentium and reversion to virulence of an nleB mutant. The activity of NleB suggests that EPEC and other attaching and effacing pathogens antagonize deathreceptor-induced apoptosis of infected cells, thereby blocking a major antimicrobial host response.
Members of the death receptor family such as FAS and TNFR1 contain an intracellular death domain and require caspase-8 for the activation of effector caspases and consequent cell death by the extrinsic apoptotic pathway 4, 5 . Within seconds of engagement by Fas ligand (FasL), pre-associated FAS trimers undergo multimerization and recruit the death-domain-containing adaptor protein FADD through heterotypic death domain interactions 5 . FADD then recruits pro-caspase-8 forming the death-inducing signalling complex (DISC), whereupon caspase-8 undergoes conformational change, auto-proteolytic processing and release from the DISC to allow cleavage of cytosolic substrates, including pro-caspase-3 and Bid 5 . Similarly, upon stimulation by TNF, TNFR1 recruits the adaptor protein TRADD and the receptor kinase, RIPK1, leading to NF-kB activation. Alternatively, cell death may be induced through TNFR1 internalisation and formation of a secondary complex that contains TRADD/RIPK1/FADD and caspase-8 (refs 6, 7) .
Previously, we reported that the EPEC T3SS effector NleB1 inhibited IkB degradation in cells upon stimulation with TNF but not IL-1b, suggesting that NleB1 interfered with death receptor signalling 8 . To identify host cell binding partners of NleB1, we screened a yeast twohybrid complementary DNA (cDNA) library derived from HeLa cells using NleB1 as bait. FADD and RIPK1, were recovered several times. Transformation into a different yeast strain demonstrated that the interaction of NleB1 with FADD and RIPK1 occurred through their respective death domains ( Fig. 1a -c). Studies in transfected HEK293T cells showed that FADD-Flag, TRADD-Flag and RIPK1-Flag copurified with an EGFP-NleB1 (EGFP, enhanced green fluorescent protein) fusion protein as well as a 2HA-tagged NleB1 translocated during EPEC E2348/69 infection ( Fig. 1d and Extended Data Fig. 1a , b). The death domain of FADD was required for binding to NleB1 from different attaching and effacing pathogens ( Fig. 1d and Extended Data Fig. 1b ). As TRADD and RIPK1 are critical components of the TNFR1 signalling complex, we investigated the influence of NleB1 on inhibition of the NF-kB dependent cytokine, IL-8, during EPEC infection. Unlike NleE, a known inhibitor of NF-kB activation 8, 9 , neither NleB1 nor its close homologue NleB2 appeared to inhibit IL-8 production during EPEC infection (Extended Data Fig. 1c ). Therefore we focused our attention on FADD-dependent apoptosis signalling. After treatment with FasL, HeLa cells transfected with pEGFP-NleB1 showed significantly higher levels of MTT (3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide) reduction (mitochondrial activity assay) compared to pEGFP transfected cells ( Fig. 1e ), suggesting that NleB1 blocked cell death. Immunoblot analysis with an antibody that recognizes only cleaved caspase-8, revealed that FasL-induced caspase-8 cleavage was substantially reduced in HeLa cells transfected with pEGFP-NleB1 ( Fig. 1f ). By immunofluorescence microscopy, fewer cells expressing EGFP-NleB1 contained cleaved caspase-8 after treatment with FasL (Extended Data Fig. 1d, e ). In contrast, a comparable number of cells contained cleaved caspase-3 in untransfected, EGFP and EGFP-NleB1 expressing cells treated with tunicamycin (Extended Data Fig. 1e ). This indicated that NleB1 had no effect on activation of the intrinsic apoptotic pathway. NleB from the murine attaching and effacing pathogen C. rodentium was recently described as an N-acetylglucosamine (GlcNAc) transferase and a member of the glycogenin family of enzymes 10 . Given the ability of NleB1 to bind FADD and inhibit proteolytic activation of caspase-8, we examined whether FADD was post-translationally modified by NleB1. Following incubation with GST-NleB1 and UDP-GlcNAc, we observed GlcNAc modification of His-FADD ( Fig. 2a ). This modification was not present upon incubation with an NleB1 catalytic site mutant (NleB1 AAA ) 10 . Similar modification of FADD-Flag occurred upon ectopic expression of EGFP-NleB1 in HeLa cells (Extended Data Fig. 1f ). Intact protein liquid chromatography-mass spectrometry (LC-MS) of His-FADD incubated with GST-NleB1 and UDP-GlcNAc revealed a mass shift matching a single GlcNAc modification on FADD (Fig. 2b) Table 1 ). This was confirmed by substitution of Arg 117 in FADD with alanine, whereas alanine substitution at Ser 122 had no effect on NleB-mediated N-acetylglucosylation (Extended Data Fig. 4 ). Arg 117 is located at the interface of the FAS-FADD death domain interaction and is critical for assembly of the FAS-FADD oligomeric complex and formation of the DISC 11, 12 . Accordingly, EGFP-NleB1 but not catalytically inactive EGFP-NleB1 AAA inhibited caspase-8 activation ( Fig. 2d ). During infection, NleB1 delivered by the EPEC T3SS inhibited FasL-induced caspase-8 activation in HeLa cells. This inhibition was lost in cells infected with an DescN mutant that has a non-functional T3SS, or an DnleB1/B2 double mutant ( Fig. 2e-g) . Complementation of the DnleB1/B2 mutant with nleB1 but not nleB2 restored the ability of EPEC to inhibit caspase-8 activation ( Fig. 2e-g) , demonstrating that the two NleB proteins have distinct functions. This mirrored our protein interaction studies, which showed that NleB2 did not interact with FADD or TRADD and bound only weakly to RIPK1 (Extended Data Fig. 5a-d ).
Arg 117 in FADD is essential for FAS-FADD and TRADD-FADD death domain interactions 11, 12 . Consistent with the role of NleB1 in inhibition of FADD-dependent caspase-8 activation, an nleB1 mutant was unable to inhibit FasL-or TNF-induced activation of caspase-8 whereas the complemented strain was as effective as wild-type EPEC ( Fig. 3a and Extended Data Fig. 5e , f). EPEC expressing NleB1 also inhibited FasL-induced apoptosis as measured by propidium iodide (PI) staining (Fig. 3b, c) . These phenotypes were not due to differences in adherence (Extended Data Fig. 5g ).
NleB1 N-acetylglucosamine transferase activity was required for inhibition of FasL-induced caspase-8 processing during infection ( Fig. 3d ). To examine the influence of NleB1 on FAS DISC assembly, which precedes caspase-8 activation, we immunoprecipitated the FAS receptor complex from infected HeLa cells treated with FasL ( Fig. 3e ). Prior infection of cells with EPEC substantially inhibited FasL-induced DISC formation and this required NleB1 N-acetylglucosamine transferase activity (Fig. 3e ).
We next examined the effect of NleB on inhibition of caspase-8 processing in vivo by infecting wild-type C57BL/6 mice with C. rodentium or a DnleB mutant of C. rodentium and staining tissue sections for cleaved caspase-8. Although few cells were positive for cleaved caspase-8 during C. rodentium infection, significant numbers of cells were positive for cleaved caspase-8 during infection with the DnleB mutant ( Fig. 4a ). Many of these caspase-8 positive cells were present as sloughed cells in the gut lumen (Extended Data Fig. 6a ).
The observation that NleB1 inhibited FasL-induced caspase-8 cleavage suggested that FAS-mediated apoptosis contributes to host defence against attaching and effacing pathogens. We tested this by infecting FAS-deficient Fas lpr/lpr mutant mice with C. rodentium 13 . As shown previously, nleB was essential for efficient colonization of wild-type C57BL/6 mice 14 (Fig. 4b ). Although there was no difference in faecal shedding of C. rodentium between C57BL/6 and Fas lpr/lpr mice during the acute phase of infection (first 12 days) ( Fig. 4b ), Fas lpr/lpr mice developed severe, watery diarrhoea ( Fig. 4c ). In addition, C. rodentium penetrated the crypts in Fas lpr/lpr mice, unlike in C57BL/6 mice in which the bacteria were predominantly located at the tips of the villi (Fig. 4d ). To study the resolving phase of infection (post day 12), C57BL/6 and Fas lpr/lpr mice were infected with a lower dose of C. rodentium to avoid the rapid onset of severe diarrhoea and monitored for up to 33 days. Fas lpr/lpr mice were impaired in their ability to clear C. rodentium compared to C57BL/6 mice ( Fig. 4e and Extended Data Fig. 6b ).
The development of severe diarrhoea in C. rodentium-infected Fas lpr/lpr mice was unexpected and sections of colon from mice infected with C. rodentium for 10 days were examined to identify differences in pathology between Fas lpr/lpr mice and C57BL/6 mice. Histological analysis of colons from Fas lpr/lpr mice revealed greater erosion of the epithelium (tissue damage) as well as increased colon weight and crypt height compared to C57BL/6 mice (measures of C. rodentium induced intestinal hyperplasia 14 ) (Extended Data Fig. 7a-d ). In addition, Fas lpr/lpr mice showed more pronounced neutrophil infiltration, which penetrated across the muscularis mucosa (Extended Data Fig. 7e ). Similar phenotypes were observed in FasL-deficient Fas gld/gld mice and Bid-deficient mice (Fig. 4d , e and Extended Data Fig. 8 ). Bid is not required for FasL-induced apoptosis in lymphoid cells, but is required for FasL-induced apoptosis in several other cell types 15, 16 . This suggests that FAS signalling in epithelial cells rather than lymphoid cells limits C. rodentium-induced colitis.
We reasoned that if NleB interfered with FAS-mediated apoptosis signalling during infection, then C. rodentium DnleB mutant bacteria would no longer be attenuated in mice that carry defects in this apoptosis pathway. Indeed, Fas lpr/lpr mice infected with the DnleB mutant showed comparable levels of bacterial colonization and severity of diarrhoea compared to their littermates infected with C. rodentium (Extended 
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Data Figs 6b and 9a, b). The same was not true for DespI or DespF mutants of C. rodentium, which retained their known colonization defects in Fas lpr/lpr mice (Extended Data Fig. 9c, d) 17, 18 . EspI and EspF are T3SS effector proteins with functions unrelated to NleB1 and the inhibition of FAS signalling. During infection with attaching and effacing pathogens, the predominant site of NleB activity is in enterocytes where the translocation of bacterial effector proteins occurs 1 . NleB-mediated inhibition of FasL/ FAS-induced apoptosis may prolong bacterial attachment to host cells and thereby promote bacterial shedding in the faeces. Indeed NleB is associated with the transmission of C. rodentium amongst littermates 19 and is epidemiologically associated with outbreaks of haemolytic uraemic syndrome caused by EHEC 20, 21 . Conversely, the reduced colonization of C57BL/6 mice by C. rodentium DnleB mutants and increased numbers of activated caspase-8 positive cells may reflect partial protection by the FAS apoptotic pathway through the elimination of infected cells 14 . This is consistent with the prolonged shedding of C. rodentium in FAS-deficient animals compared to C57BL/6 mice. The increased intestinal pathology observed in C. rodentium-infected FAS-, FasL-and Bid-deficient mice has also revealed a function for the FAS apoptotic pathway in limiting the extent of colitis during gastrointestinal infection. This aggravation of disease may be mirrored in humans, as nucleotide polymorphisms in the FASLG gene, encoding FasL, have been associated with the development of inflammatory bowel disease 22 . In summary, the discovery of a bacterial T3SS effector that specifically modifies death domain containing proteins through a newly identified post-translational modification and thereby inhibits death receptor mediated apoptosis has revealed a new virulence mechanism in bacterial infection.
METHODS SUMMARY
Detailed information including bacterial mutant construction, immunofluorescence, immunoblot details, mouse infections, histology and pathology scoring, imaging and image analysis, and associated references are included in the Methods. Protein interaction assays were investigated using the yeast two-hybrid system and co-immunoprecipitation. Activation of caspase-8 was assessed by immunoblot and immunofluorescence microscopy using antibodies specific for cleaved caspase-8. Cell death was examined by MTT reduction and propidum iodide staining. Post-translational modifications of FADD were identified by intact protein mass spectrometry and collision-induced dissociation (CID) and electron transfer dissociation (ETD) peptide fragmentation. All genetically modified and spontaneous mutant mice are on a C57BL/6 background and all animals were inoculated by oral gavage with 200 ml containing approximately 1 3 10 9 or 1 3 10 8 c.f.u. of C. rodentium. All animal experimentation was approved by the University of Melbourne Animal Ethics Committee, applications 0808209 and 1112062.
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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METHODS
Bacterial strains, plasmids, yeast strains and growth conditions. The bacterial strains, yeast strains and plasmids used in this study are listed in Supplementary Table 2 .
All PCR primers are listed in Supplementary Table 3 . Bacteria were grown at 37 uC in Luria-Bertani (LB) medium or Dulbecco's modified Eagle's medium (DMEM) (Gibco) where indicated and supplemented with ampicillin (100 mg ml 21 ), kanamycin (100 mg ml 21 ), nalidixic acid (50 mg ml 21 ) or chloramphenicol (25 mg ml 21 ) when necessary. Yeast strains were grown at 30 uC in YPD (yeast extract/peptone/dextrose) medium or yeast nitrogen minimal medium supplemented with 2% glucose and amino acids including histidine (20 mg ml 21 ), methionine (20 mg ml 21 ), tryptophan (20 mg ml 21 ), adenine (20 mg ml 21 ), uracil (20 mg ml 21 ) and leucine (30 mg ml 21 ) when necessary. For infection of HeLa cells, overnight cultures of EPEC grown in LB medium were subcultured 1:50 into DMEM and grown statically for 3-4 h at 37 uC with 5% CO 2 . The optical density (D 600 nm ) of the bacterial cultures was measured to standardize the inoculum before infection. Cultures were induced with 1 mM isopropyl-B-D-thiogalactopyranoside (IPTG) for 30 min before infection.
Construction of NleB, TRADD, RIPK1 and FADD expression vectors. The plasmids and primers used in this study are listed in Supplementary Tables 2 and TRADD-Flag was kindly provided by J. Tschopp. FADD-Flag and RIPK1-Flag were provided by A. Mansell. To generate FADD DDD -Flag, the coding region for amino acids 1-96 of FADD was amplified by PCR from FADD-Flag using the primer pairs FADD F /FADD DDDR and ligated into EcoRI/BamHI digested p33Flag-Myc-CMV to generate an N-terminal 33Flag fusion to FADD 1-96 (FADD DDD -Flag). To generate His-FADD, FADD was amplified from FADD-Flag using the primer pairs FADD HISF /FADD HISR and ligated into BamHI/SalI digested pET28a.
To generate pGBT-NleB1, nleB1 was amplified from EPEC E2348/69 or EHEC O157:H7 EDL933 genomic DNA by PCR using primer pairs NleB1 EPGBTF /NleB1 R or NleB1 EHGBTF /NleB1 EHR (pGBT-NleB1 and pGBT-NleB1 EH ). The PCR products were digested with SmaI/EcoRI and EcoRI/BamHI, respectively and ligated into pGBT9. The plasmids pGAD-FADD DED and pGAD-FADD DD were generated from the template pGAD-FADD recovered from the cDNA library screen using primer pairs FADD GADF /FADD DEDR and FADD DDF /FADD GADR , respectively. The FADD DED and FADD DD PCR products were digested with EcoRI/ HindIII and EcoRI/SalI, respectively, and ligated into pGAD424. The pGAD-RIPK1 DD plasmid was generated using primers RIPK1 DDF /RIPK1 GADR using pGAD-RIPK1 recovered from the cDNA library screen as template DNA, and cloned using the EcoRI and BamHI restriction sites. Construction of non-polar deletion mutants. C. rodentium strain ICC169 DnleB (ICC911) was constructed using the lambda Red-based mutagenesis system 23 . The nleB gene was replaced by a kanamycin resistance cassette following integration of a linear PCR product generated using the primers pair crNleB-pKD4-Fw/crNleB-pKD4-Rv, which contain 50 nucleotide homology extensions corresponding to regions in 59 and 39 of the nleB open reading frame and priming sequences for the kanamycin cassette of plasmid pKD4 ( Supplementary Table 3 ) 23 . The PCR product was DpnI-digested to remove residual template, gel purified and electroporated into ICC169 carrying the temperature-sensitive lambda Red helper plasmid pKD46 following induction of lambda Red recombinase with 10 mM L-arabinose at 30 uC. The deletion mutant of C. rodentium nleB was confirmed by PCR and DNA sequencing and the growth rates of the mutant and parental strains were assessed in rich and minimal media. The C. rodentium strains ICC169 DespI (ICC179) and ICC169 DespF (ICC177) have been described previously 17 . EspI binds to Sec24 and inhibits COPII-dependent vesicle trafficking while EspF is a multifunctional effector that has been associated with destabilization of mitochondria, induction of apoptosis, activation of sorting nexin 9 and disruption of tight junctions 1 . These mutants were chosen as controls because they exhibit varying degrees of attenuation in the mouse model of C. rodentium infection and have functions unrelated to NleB.
The EPEC E2348/69 nleB1 mutant was created with the one step PCR lambda Red method using primers NleB1 E69FRT F155 and NleB1 E69FRT R156 . pKD3 was used as template DNA to amplify the chloramphenicol cassette. The cassette was electroporated into wild-type EPEC E2348/69 and positive clones were selected on LB agar with 5 mg ml 21 chloramphenicol. The mutations were checked by PCR using primer pairs from outside and inside the mutation. The EPEC E2348/69 nleB2 mutant was created using primers NleB2 E69FRT F115 and NleB2 E69FRT R116 . pKD4 was used as template DNA to amplify the kanamycin cassette. The cassette was electroporated into wild-type EPEC E2348/69 and positive clones selected for on LB agar with 50 mg ml 21 kanamycin. The mutations were checked by PCR with a combination of primers from outside and inside the mutation. The EPEC E2348/69 nleB1/nleB2 double mutant was generated using the one step PCR method by amplifying the nleB2 mutation from the nleB2 mutant with primers NleB2 212 and NleB2 213 . The PCR product was transferred into the nleB1 mutant strain by electroporation. Mutants were first selected on LB agar plates with 20 mg ml 21 of kanamycin and then grown with chloramphenicol (25 mg ml 21 ) and kanamycin (50 mg ml 21 ) to select for nleB1 and nleB2 allelic replacement. Site-directed mutagenesis. The His-FADD R117A and His-FADD S122A mutants, and the NleB1 mutants, pNleB1 AAA , EGFP-NleB1 AAA and pGEX-NleB1 AAA were generated using the Stratagene QuikChange II Site-Directed Mutagenesis Kit. FADD R117A and FADD S122A were generated by PCR using the primer pairs FADD (R117A)F /FADD (R117A)R and FADD (S122A)F /FADD (S122A)R , respectively with His-FADD as template DNA. For the NleB mutants, pNleB1, EGFP-NleB1 or pGEX-NleB1 were used as template DNA and amplified by PCR using the primer pair pNleB1 (AAA)F /pNleB1 (AAA)R . Plasmids were digested with DpnI at 37 uC overnight before subsequent transformation into the appropriate E. coli strain. Yeast two-hybrid screening and b-galactosidase assay. NleB1 from EPEC strain E2348/69 (GenBank accession CAS10779) and NleB1 from EHEC O157:H7 strain EDL933 (GenBank accession NP_289553.1) were used as bait. The BD Matchmaker pre-transformed HeLa cDNA library (Clontech) was screened according to the manufacturer's protocols (Clontech PT3183-1 manual) to identify HeLa proteins interacting with NleB. The yeast strain AH109 (MATa) was transformed with pGBT-NleB using the lithium acetate method and mated with Y187 (MATa) carrying the cDNA library in pGADT7 Rec plasmid. The mating mixtures were plated onto quadruple drop-out plates (Trp 2 , Leu 2 , Ade 2 , His 2 ) to select for diploids expressing reporter genes. The pGADT7-Rec cDNA plasmids were selectively rescued from those diploids with positive protein interactions into E. coli KC8. The pGADT7-Rec cDNA plasmids were then sequenced using primer Rec744 to identify the cDNA inserts.
b-galactosidase assays were performed according to the manufacturer's protocols (Clontech PT3024-1 manual). Briefly, pGADT7-Rec plasmid alone or with pGBT-NleB (or pGBT9, pGAD-FADD, pGAD-FADD DED , pGAD-FADD DD when necessary) were transformed into Saccharomyces cerevisiae strain PJ69-4A using the lithium acetate method. Transformants were selected on Trp 2 Leu 2 plates and grown to an optical density (D 600 nm ) of 0.6 before lysis and assay for the level of b-galactosidase activity using ONPG as a substrate. Data are from at least three biological replicates performed in triplicate. Bacterial adherence assay. Standard lines of HeLa and HEK293T cells are maintained in our laboratory and regularly tested for mycoplasma contamination. To assess the level of bacterial replication during infection and treatment with FasL, bacterial cultures grown in DMEM for were standardised by measurement of D 600 nm and plated on selective media for assessment by viable count. HeLa cell monolayers were infected in duplicate with the same cultures for 3 h before being incubated for 1.5 h in media supplemented with or without 20 ng ml 21 Fcc-FasL. Following treatment, cells were washed three times and attached bacteria were resuspended in DMEM by pipetting and subsequently spread on selective media for assessment of bacterial viable count. Data are from at least three biological replicates performed in triplicate. Immunoprecipitation and detection of HA-, EGFP-, Flag-tagged proteins. All immunoprecipitation experiments were performed as at least three biological replicates. For immunoprecipitation by GFP-Trap-M (Chromotek), HEK293T cells were grown in 10-cm tissue culture dishes (Greiner Bio One) and co-transfected with pEGFP-NleB1 or pEGFP-NleB2 in combination with pRIPK1-Flag, pTRADD-Flag, pFADD-Flag or pFADD DDD -Flag. Following transfection (after 18-24 h), lysis and immunoprecipitation were carried out according to instructions for immunoprecipitation of GFP-fusion proteins provided by the GFP-Trap-M supplier.
For immunoprecipitation of 23 haemagglutinin (HA) tagged proteins, HeLa cells cultured in T-75 cm 2 tissue culture flasks (Corning) were first transfected with FADD-Flag, RIPK1-Flag or TRADD-Flag expression constructs for 18 h followed RESEARCH LETTER by infection with various EPEC derivatives for 90-120 min. Cells were then washed three times with cold PBS and lysed in 1 ml cold lysis buffer (1% Triton X-100, 50 mM Tris-HCl, pH 7.4, 1 mM EDTA, 150 mM NaCl and Complete Protease Inhibitor (Roche)) and incubated on ice for 10 min before collection. Cell debris was pelleted and equal volumes of supernatant collected. 100 ml of the supernatant was kept as input and 60 ml of monoclonal anti-HA-agarose (Clone HA-7, Sigma-Aldrich) was added to the remainder of the supernatant which was incubated on a rotating wheel at 4 uC overnight. The agarose was washed three times with lysis buffer and resuspended in 50 ml of 23 SDS sample buffer.
For immunoprecipitation of Fas receptor complexes (DISC) by protein G, HeLa cells were grown in 10-cm tissue culture dishes and infected with various EPEC derivatives for 2 h. Cells were then treated with 50 mg ml 21 gentamycin and 1 mg of Fcc-FasL for 1 h. An uninfected control was left untreated. Cells were lysed in 400 ml of 23 DISC lysis buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% TritonX-100, 10% glycerol and Complete Protease Inhibitor (Roche)) and incubated on ice for 10 min before centrifugation to remove cell debris. An aliquot (80 ml) of the supernatant was kept as input and 40 ml of Protein G Dynabeads (Invitrogen) was added to the remainder of the sample which was placed on a rotating wheel at 4 uC overnight. Beads were washed three times with lysis buffer and finally resuspended in 75 ml of DISC lysis buffer with 25 ml of 53 SDS sample buffer.
All samples were boiled for 5 min, subjected to SDS-PAGE and transferred to nitrocellulose membranes. Membranes were probed with the following primary antibodies as necessary: mouse monoclonal anti-HA.11 (16B12) (Covance), mouse monoclonal anti-Flag M2-HRP (Sigma-Aldrich), mouse monoclonal anti-FADD (BD Transduction Laboratories), rabbit monoclonal anti-Fas (C18C12) (Cell Signaling), rabbit polyclonal anti-caspase-8 (D35G2) (Cell Signaling), mouse monoclonal anti-GFP (7.1 and 13.1) (Roche) or mouse monoclonal anti-b-actin (AC-15) diluted 1:1,000 in TBS with 5% BSA and 0.1% Tween. Images were visualized using an MFChemiBis imaging station (DNR). Preparation of GST and His tagged proteins, demonstration of N-acetylglucosylation of recombinant FADD by NleB1 and detection by immunoblotting. Overnight cultures of BL21 (pGEX-4T-1), BL21 (pGEX-NleB1), BL21 (pGEX-NleB1 AAA ) and BL21 (pET-FADD), BL21 (pET-FADD R117A ), BL21 (pET-FADD S122A ) grown in LB were diluted 1:100 in 200 ml of LB supplemented with either kanamycin (pET) or ampicillin (pGEX) (100 mg ml 21 ) with shaking to an optical density of (D 600 nm ) 0.6 at 37 uC. Cells were incubated with 1 mM IPTG and grown for a further 2 h then pelleted by centrifugation. Proteins were purified by either nickel or glutathione affinity chromatography in accordance with the manufacturer's instructions (Novagen). Protein concentrations were determined using a bicinchoninic acid (BCA) kit (Thermo Scientific).
For detection of N-acetylglucosylation of FADD by NleB1, 2 mg of purified recombinant proteins were incubated either alone or in combination at 37 uC for 4 h in the presence of 1 mM UDP-GlcNAc. 53 SDS sample buffer was added to the samples before boiling for 5 min. Samples were subjected to SDS-PAGE and transferred to nitrocellulose membranes which were subsequently probed with the following primary antibodies: mouse monoclonal anti-GlcNAc (CTD110.6) (Cell Signaling), which recognizes O-linked and N-linked GlcNAc 24 , rabbit polyclonal anti-GST (Cell Signaling), or mouse monoclonal anti-His (AD1.1.10) (AbD Serotech) diluted 1:1,000 in TBS with 5% BSA and 0.1% Tween. Detection and visualization were performed as previously mentioned. Detection of N-acetylglucosylated recombinant FADD was performed as three technical replicates.
For detection of N-acetylglucosylation during transient transfection with NleB1 and FADD, HEK293T cells were grown in 10-cm tissue culture dishes (Greiner Bio One) and co-transfected with pEGFP-NleB1 or pEGFP-NleB1 AAA in combination with pFADD-Flag. Cells were washed three times with cold PBS and lysed in 600 ml of cold lysis buffer (1% Triton X-100, 50 mM Tris-HCl, pH 7.4, 1 mM EDTA, 150 mM NaCl and Complete Protease Inhibitor (Roche)) and incubated on ice for 10 min before collection. Cell debris was pelleted and equal volumes of supernatant collected. Then 80 ml of the supernatant was kept as input and 40 ml of monoclonal anti-Flag M2 magnetic beads (Sigma-Aldrich) was added to the remainder of the supernatant which was incubated on a rotating wheel at 4 uC overnight. The beads were washed three times with cold lysis buffer followed by elution of bound proteins with 80 mg of Flag peptide (Sigma-Aldrich) to which 16 ml of 53 SDS sample buffer was added. Samples were boiled for 5 min, subjected to SDS-PAGE and transferred to nitrocellulose membranes. Membranes were probed with the following primary antibodies as necessary: mouse monoclonal anti-O/N-GlcNAc (CTD110.6) (Cell Signaling), mouse monoclonal anti-Flag M2-HRP (Sigma-Aldrich), mouse monoclonal anti-GFP (7.1 and 13.1) (Roche) or mouse monoclonal anti-b-actin (AC-15) diluted 1:1,000 in TBS with 5% BSA and 0.1% Tween. Images were visualized using an MFChemiBis imaging station (DNR). Glyco-site specific analysis of FADD. Intact protein analysis was performed by the Proteomics Laboratory at the Walter and Eliza Hall Institute (Fig. 2b and Extended Data Fig. 4 ). 10 mg of intact recombinant His-FADD, His-FADD R117A or His-FADD S122A incubated with GST-NleB1 and UDP-GlcNAc, was injected and separated by nano-flow reversed-phase liquid chromatography on a nano LC system (1200 series, Agilent) using a custom packed C4 capillary column (15 cm 3 0.15 mm inner diameter (I.D.), packed with Resprosil 300 Å C4 5-mm resin, Dr Maisch GmbH) using a linear 45 min gradient from 5 to 100% buffer B at a flow rate of 1.2 ml min 21 (A: 0.1% Formic acid in Milli-Q water B: 0.1% Formic acid, 80% acetonitrile, (Mallinckrodt Baker) 20% Milli-Q water). The nano HPLC was coupled online to a Q-Exactive mass spectrometer equipped with a nano-electrospray ion source (Thermo Fisher Scientific) set to acquire full scan and all-ion-fragmentation (AIF) sequentially. Mass accuracy of the intact protein was achieved by summing multiple lower resolution (35,000) full scan MS events. The intact mass and error calculation was facilitated by the open source program mMass.
Tryptic peptide analysis was performed by the Proteomics Laboratory at the Walter and Eliza Hall Institute (Fig. 2c and Extended Data Fig. 2 ). Reacted and unreacted mixtures of recombinant FADD and NleB1 were purified by SDS-PAGE and bands corresponding to FADD were excised and manual in-gel reduction, alkylation and tryptic digestion was performed. Extracted peptides were injected and separated by nano flow reversed-phase liquid chromatography on a nano LC system (1200 series, Agilent) using a nanoAcquity C18 150 mm 3 0.15 mm I.D. column (Waters) with a linear 45-min gradient from 5 to 100% buffer B set at a flow rate of 1.2 ml min 21 (A: 0.1% Formic acid in Milli-Q water, B: 0.1% Formic acid, 80% acetonitrile, (Mallinckrodt Baker, New Jersey, USA) 20% Milli-Q water). The nano HPLC was coupled online to an LTQ-Orbitrap XL mass spectrometer equipped with a nano-electrospray ion source (Thermo Fisher Scientific) for automated MS/MS using multi-stage activation (MSA) setting. The Orbitrap was run in a data-dependent acquisition mode with the Orbitrap resolution set at 30,000 and the top-three multiply charged species selected for fragmentation in the linear ion trap by collision-induced dissociation (CID) (single charged species were ignored). Fragment ions were analysed on the Orbitrap with the resolution set at 7,500 with the ion threshold set to 15,000 counts. The activation time was set to 30 ms, normalized collision energy set to 35. Raw files consisting of full-scan MS and high resolution MS/MS spectra were converted to the MGF data format with Proteome Discoverer 1.4 and searched against UniProt database (2013/02) limiting the search to mouse taxonomy and custom FASTA database containing the protein constructs of FADD and NleB using Mascot v2.4. Mascot parameters for each search included Trypsin/no P enzyme with six missed cleavages, a fixed modification in the form of carbamidomethyl at cysteine residues and variable modification of HexNAc at Ser/Thr/Asn/Arg residues, acetyl at protein N-terminal, oxidation at methionine residues. Spectra were searched with a mass tolerance of 20 p.p.m. in MS mode and 40 m.m.u. in MS/MS mode. The MS/MS fragmentation of modified peptides obtained from the Mascot search was manually sequenced using mMass to assign ion peaks and confirm the site of modification. Detection of N-acetylglucosylated recombinant FADD by mass spectrometry was performed as two technical replicates.
The site of modification was verified independently using electron transfer dissociation (ETD) fragmentation on an Orbitrap Elite mass spectrometer by the Bio21 Mass Spectrometry and Proteomics Facility at the University of Melbourne (Extended Data Fig. 3 ). The protein complex was digested with Endoproteinase AspN (Roche) at an enzyme to protein ratio of 1:5 at 37 uC overnight. The reaction contained FADD, NleB1 and UDP-GlcNAc and the incubation was performed as described earlier for anti-GlcNAc immunoblot analysis. LC-MS/ MS was carried out on a LTQ Orbitrap Elite (Thermo Scientific) with an EASY nano electrospray interface coupled to an Ultimate 3000 RSLC nanosystem (Dionex). The nanoLC system was equipped with a Acclaim Pepmap nano-trap column (Dionex -C18, 100 Å , 75 mm 3 2 cm) and a Thermo EASY-Spray column (Pepmap RSLC C18, 2 mm, 100 Å , 75 mm 3 25 cm). 4 ml of the peptide mix was loaded onto the enrichment (trap) column at an isocratic flow of 4 ml min 21 of 3% CH 3 CN containing 0.1% formic acid for 5 min before the enrichment column was switched in-line with the analytical column. The eluents used for the liquid chromatography were 0.1% (v/v) formic acid (solvent A) and 100% CH 3 CN/0.1% formic acid (v/v). 0.1% formic acid (v/v). The flow following gradient was used: 3% B to 12% B for 1 min, 12% B to 35% B in 20 min, 35% B to 80% B in 2 min and maintained at 80% B for 2 min and equilibration at 3% B for 7 min before the next sample injection. The LTQ Orbitrap Elite mass spectrometer was operated in the data dependent mode with nano ESI spray voltage of 12.0 kV, capillary temperature of 250 uC and S-lens RF value of 60%. A sequential mode whereby spectra were acquired first in positive mode with full scan scanning from m/z 300-1650 in the FT mode at 120,000 resolution followed by CID, ETD and high energy collision dissociation (HCD). CID in the linear ion trap was carried out in parallel with three most intense peptide ions with charge states $ 2 isolated and fragmented using normalized collision energy of 35 and activation Q of 0.25. The decision tree procedure for ETD activation was also applied whereby peptides with charge state LETTER RESEARCH 3 of ,650 m/z, charge state 4 of ,900 m/z and charge state 5 of ,1,000 m/z were subjected to 100 ms of ETD activation. HCD at 15,000 resolution using normalized collision energy of 35 and 0.1 ms activation time was carried out on every precursor selected. The mass spectra were searched against the Uniprot database using the Sequest HT (V1.3) search algorithm as part of the Proteome Discoverer 1.4 Workflow (Thermo Scientific). Searching parameters used were: variable modifications (HexNAc of N, S, T and R; 203.079), 2 missed tryptic cleavages, 10 p.p.m. peptide mass tolerance and 0.6 Da fragment ion mass tolerance. The false-discovery rate (derived from corresponding decoy database search) was less than 1%. Peptides of interest were manually inspected and validated. IL-8 secretion assay. For analysis of IL-8 secretion, HeLa cell monolayers were infected for 3 h before being incubated for 8-12 h in media supplemented with 50 mg ml 21 gentamycin with or without 20 ng ml 21 TNF (Calbiochem, EMD4Biosciences). Following this, the HeLa cell supernatant was collected and either used immediately or stored at 220 uC for subsequent analysis of IL-8 secretion. IL-8 secretion was measured using the Quantikine Human IL-8 Immunoassay (R&D Systems) according to the manufacturer's instructions. Samples were measured on a FLUOstar Omega microplate reader (BMG Labtech). Differences in IL-8 secretion were assessed for significance by one-way analysis of variance (ANOVA) with Dunnett's multiple comparison post-test. Data are from at least three biological replicates performed in triplicate. Detection of cleaved caspase-8 by immunoblotting. For detection of cleaved caspase-8 during EPEC infection, HeLa cells were grown in 24-well tissue culture plates (Greiner Bio One) and infected for 3 h with various EPEC derivatives. Cells were then treated with 50 mg ml 21 gentamicin, and either 20 ng ml 21 of Fcc-FasL, 20 ng ml 21 TNF or a combination of 20 ng ml 21 TNF and 10 mg ml 21 cycloheximide for a further 60 min and lysed in 60 ml of 23 SDS sample buffer. For detection of cleaved caspase-8 by transfection, HeLa cells were grown in 24-well tissue culture plates and either left untransfected or transfected with pEGFP-C2, pEGFP-NleB1 or pEGFP-NleB1 AAA for 18-24 h using FuGENE 6 (Roche). Cells were then treated with 20 ng ml 21 of Fcc-FasL for a further 60 min and collected by lysis in 60 ml of 23 SDS sample buffer. All samples were boiled for 5 min and subjected to SDS-PAGE followed by transfer to nitrocellulose membranes (PALL). Membranes were incubated at least overnight at 4 uC with rabbit polyclonal anti-cleaved caspase-8 (Asp391) (18C8) (Cell Signaling) diluted 1:1,000 in TBS with 5% skimmed milk and 0.1% Tween (Sigma-Aldrich), rabbit polyclonal anti-caspase-8 (D35G2) (Cell Signaling) diluted 1:1,000 or mouse monoclonal anti-b-actin (AC-15) (Sigma-Aldrich) diluted 1:5,000 in TBS with 5% BSA (Sigma-Aldrich) and 0.1% Tween. Proteins were detected using anti-rabbit or anti-mouse IgG secondary antibodies conjugated to horseradish peroxidase (PerkinElmer) and developed with either enhanced chemiluminescence (ECL) western blotting reagent (Amersham) or Western Lightning Ultra reagent (PerkinElmer). All secondary antibodies were diluted 1:3,000 in TBS with 5% BSA and 0.1% Tween. Images were visualized using an MFChemiBis imaging station (DNR). At least three biological replicates were performed for all experiments. Detection of cleaved caspase-8 and caspase-3 in vitro by immunofluorescence microscopy. For visualization of caspase-8 cleavage by immunofluorescence microscopy, HeLa cells were either infected with EPEC E2348/69 derivatives for 3 h or transfected for 16 h followed by an additional 1 h of treatment with 20 ng ml 21 Fcc-FasL. One experiment used recombinant rhFasL to treat transfected HeLa cells for comparison with tunicamycin treatment (Extended Data Fig. 1d, e ). For this, HeLa cells were transfected for 16 h and treated with 200 ng ml 21 of rhFasL (R&D Systems). For visualization of caspase-3 cleavage induced by tunicamycin, HeLa cells were transfected for 16 h, followed by 18 h treatment with 5 mg ml 21 tunicamycin (Sigma-Aldrich). Cells were then fixed in 3.7% (w/v) formaldehyde (Sigma-Aldrich) in PBS for 10 min and permeabilized with 0.2% Triton (Sigma-Aldrich) for 4 min. Following 30 min blocking in PBS with 3% (w/v) BSA, samples were exposed to primary antibodies (specific to cleaved caspase-8 or cleaved caspase-3; Cell Signaling Technology) diluted in blocking solution for 1 h at 20 uC, except for cleaved caspase-3, which was incubated overnight at 4 uC. For fluorescent actin staining in EPEC infected cells, 0.5 mg ml 21 of phalloidin conjugated to rhodamine (Sigma-Aldrich) was added during primary antibody incubation. 4',6-diamidino-2-phenylindole (DAPI, Invitrogen) was applied at 0.5 mg ml 21 in blocking solution for 5 min at 20 uC post-secondary antibody treatment. Secondary antibodies were all coupled to Alexa Fluor dyes (Invitrogen) applied to cells at 1:2,000 in blocking solution for 1 h at 20 uC. Coverslips were mounted onto microscope slides with Prolong Gold anti-fade reagent (Invitrogen). Images were acquired using a Zeiss confocal laser scanning microscope with a 1003/EC Epiplan-Apochromat oil immersion objective. Cleavage of caspase-8 or caspase-3 was quantified from at least three biological replicates performed in duplicate for both transfection and infection studies counting at least 100 cells per field.
Cell viability assays (MTT and propidium iodide staining). HeLa cells were transfected in 24-well tissue culture plates for 18-24 h before being left untreated or treated with 20 ng ml 21 of Fcc-FasL for a further 60 min. The cells were washed once with PBS and replaced with DMEM containing 0.1 mg ml 21 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma) for 1 h, after which the medium was removed and 100 ml of dimethylsulphoxide (DMSO, Sigma) was added to each well. After thorough mixing on an orbital shaker for 1 min, the absorbance at 540 nm for each well was obtained using a FLUOstar Omega microplate reader (BMG Labtech). Results were obtained from at least three biological replicates performed in triplicate.
For analysis of cell viability by PI staining, HeLa cell monolayers were infected for 3 h before being incubated for 1 h in media supplemented with 50 mg ml 21 gentamycin with 20 ng ml 21 Fcc-FasL. Propidium iodide (50 mg ml 21 ) was added for the final 15 min of treatment. Cells were fixed and stained for confocal microscopy as previously mentioned. Phalloidin conjugated to FITC (Sigma-Aldrich) was used at 0.5 mg ml 21 to stain for actin. Duplicate coverslips were counted for PI positive cells, and results were obtained from at least three biological replicates counting at least 100 cells per field. Animal experiments. All animal experimentation was approved by the University of Melbourne Animal Ethics Committee, applications 0808209 and 1112062. All genetically modified and spontaneous mutant mice are on a C57BL/6 background. Overnight cultures of bacterial strains were pelleted by centrifugation and resuspended in PBS. C57BL/6 (wild-type), Fas lpr/lpr , Fas gld/gld and Bid 2/2 mutant mice (6 to 8 weeks old, male and female mice) were inoculated by oral gavage with 200 ml containing approximately 1 3 10 9 c.f.u. of C. rodentium, or a lower dose of 1 3 10 8 c.f.u. when testing for prolonged infection (up to 33 days). The viable count of the inoculum was determined retrospectively by plating dilutions of the inoculum on plates with appropriate antibiotics. Animals were allocated to experimental groups to ensure even distribution of age, sex and weight. Investigators were not blinded to group allocation. Sample size was at least five animals per group for statistical power per biological replicate. Larger sample sizes (up to 12 mice per group) were used if mice were available. Infection experiments were repeated at least twice regardless of sample size to ensure reproducibility and results represent all experimental data combined from repeated infections. Mice were weighed every 2 days and faeces collected every 2 or 4 days for enumeration of c.f.u. The viable bacterial count per 100 mg of faeces was determined by plating serial dilutions in duplicate of faeces onto medium containing selective antibiotics. Histological analysis and scoring of tissue pathology and diarrhoea. The increased intestinal pathology observed in C. rodentium-infected FAS-, FasLand Bid-deficient mice revealed a function for the FAS apoptotic pathway in limiting the extent of colitis during gastrointestinal infection. This exacerbated disease compared to C. rodentium infection of wild-type mice likely arose from the difference between a complete block of FAS signalling in the gut epithelium of FAS-deficient mice as opposed to less complete inhibition of FAS signalling in the gut epithelium by NleB in wild-type mice, which depends on the timing and efficiency of C. rodentium attachment and NleB translocation. A grading system for diarrhoea was developed in which a score of diarrhoea severity from 0-4 was recorded every 4 days. The scoring system can be interpreted as follows, (0) (no diarrhoea): solid stool with no sign of soiling around the anus. The stool is very firm when subjected to pressure with tweezers; (1) (very mild diarrhoea): formed stools that appear moist on the outside, and no sign of soiling around the anus. Stool is less firm when considerable pressure applied with tweezers; (2) (mild diarrhoea): formed stools that appear moist on the outside, and some signs of soiling around anus. Stools will easily submit to pressure applied with tweezers;
(3) (diarrhoea): no formed stools with a mucous-like appearance. Considerable soiling around the anus and the fur around tail. Mouse takes a long time to pass stool; (4) (severe, watery diarrhoea): mostly clear or mucous-like liquid stool with very minimal solid present and considerable soiling around anus. Mouse may not be able to pass stool at all and may have a hunched appearance. Occasionally, blood may be observed in the stool.
For histological analysis, mice inoculated with the higher dose of C. rodentium (1 3 10 9 c.f.u.) were culled at day 10 or 12 post-infection and the distal portion of colon from the caecum to the rectum removed aseptically and weighed after removal of faecal pellets. Colons and spleens were homogenized mechanically in PBS using a Seward 80 stomacher, and the bacterial c.f.u. per 100 mg of organ homogenate was enumerated by plating onto LB containing the appropriate antibiotics. Colons from a representative group of these mice were collected and fixed in 4% (w/v) paraformaldehyde (Sigma-Aldrich) and sectioned for haematoxylin and eosin staining and assessment of gut pathology. A scoring system (0-3) was used by a veterinary pathologist to assess the extent of tissue damage: (0) no damage;
(1) discrete lesion; (2) mucosal erosion; and (3) extensive mucosal damage/ulceration (extending into muscularis and deeper).
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Extended Data Figure 5 | Comparison of FasL and TNF-mediated caspase-8 processing and analysis of NleB2. a, GFP-Trap pull-down of FADD-Flag, TRADD-Flag or RIPK1-Flag with EGFP-NleB2 in HEK293T cells. Actin, loading control. Representative immunoblot from at least three independent experiments. b-d, Co-immunoprecipitation of bacterially delivered NleB2-2HA with FADD-Flag, TRADD-Flag and RIPK1-Flag in HeLa cells using HA antibodies. Lane 1, HeLa cells infected with EPEC DnleB2 (pNleB2) (negative control). Lane 2, HeLa cells infected with EPEC DnleB2 (pNleB2-2HA). Actin, loading control. Representative immunoblots from at least three independent experiments. e, Unprocessed and cleaved caspase-8 in HeLa cells infected for 3 h with derivatives of EPEC and left untreated or treated with Fcc-FasL or TNF for 1 h, as indicated. Representative immunoblot from at least three independent experiments. f, Unprocessed and cleaved caspase-8 in HeLa cells infected for 45 min with derivatives of EPEC and left untreated or treated with TNF and cyclohexamide (CHX) for 1 h as indicated. Actin, loading control. Representative immunoblot from at least three independent experiments. g, Adherence of EPEC to HeLa cells. HeLa cells were infected with derivatives of EPEC for 3 h followed by treatment with FasL for 1 h. Number of recovered bacteria and the inoculum are shown for comparison. Mean 6 s.e.m. are indicated. Data are from three independent experiments performed in triplicate.
